Results 61 to 70 of about 100,116 (343)
Introduction: The reported incidence of ventilator-associated pneumonia (VAP) in Wales is low compared with surveillance data from other European regions.
Richard Pugh +6 more
doaj +1 more source
Профилактика инфекций при тяжелых повреждениях мозга: акцентирование на вентилятор-ассоциированную пневмонию и наружное вентрикулярное дренирование [PDF]
Вентилятор-ассоциированная пневмония у пациентов с тяжелой черепно-мозговой травмой может достигать 40 %, и это в значительной степени связано с длительным воздействием механической вентиляции легких.
Базиленко, Д.В. +4 more
core
Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih +3 more
wiley +1 more source
The effectiveness of a bundle in the prevention of ventilator-associated pneumonia
Objectives: The aim of this study was to evaluate the impact of a bundle called FAST HUG in ventilator-associated pneumonia, weigh the healthcare costs of ventilator-associated pneumonia patients in the intensive care unit, and hospital mortality due to ...
Cléria Rodrigues Ferreira +6 more
doaj +1 more source
Ventilator-associated Pneumonia: A Study of Patients admitted in Internal Intensive Care Unit of Ali Asghar Hospital, Shiraz [PDF]
Introduction: Ventilator-associated pneumonia is defined as a pneumonia occurring in patients within 48 hours or more after intubation with an endotracheal tube or tracheostomy tube and which not present before.
Bahtouee, Mehrzad +2 more
core
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart +7 more
wiley +1 more source
Ventilator-associated pneumonia (VAP) has been described in humans and in experimental animals. The most severe lesions are located in dependent lung segments along a sterno-vertebral axis, however the cephalocaudal distribution of lung infection remains
Vieira Silvia Regina Rios +4 more
doaj
Frequency of Ventilator-associated Pneumonia With 3-day Versus 7-day Ventilator Circuit Changes
Ventilator-associated pneumonia (VAP) is a common clinical problem. Previous studies involving adult patient cohorts have assessed various risk factors associated with VAP, including ventilator circuit changes.
Ting-Chang Hsieh +5 more
doaj +1 more source
Pencegahan Ventilator-associated Pneumonia dengan Pemberian Profilaksis Stress Ulcers [PDF]
Ventilator-associated pneumonia (VAP) adalah pneumonia yang terjadi lebih dari 48 jam setelah pemasangan intubasi endotrakeal akibat dari mikroorganisme yang masuk saluran pernapasan bagian bawah melalui aspirasi sekret orofaring yang berasal dari ...
Anandani, A. (Adinta)
core

